Optimal Trade-off Control in Machine Learning-based Library Design, with Application to Adeno-associated Virus (AAV) for Gene Therapy
Authors
Affiliations
Adeno-associated viruses (AAVs) hold tremendous promise as delivery vectors for gene therapies. AAVs have been successfully engineered-for instance, for more efficient and/or cell-specific delivery to numerous tissues-by creating large, diverse starting libraries and selecting for desired properties. However, these starting libraries often contain a high proportion of variants unable to assemble or package their genomes, a prerequisite for any gene delivery goal. Here, we present and showcase a machine learning (ML) method for designing AAV peptide insertion libraries that achieve fivefold higher packaging fitness than the standard NNK library with negligible reduction in diversity. To demonstrate our ML-designed library's utility for downstream engineering goals, we show that it yields approximately 10-fold more successful variants than the NNK library after selection for infection of human brain tissue, leading to a promising glial-specific variant. Moreover, our design approach can be applied to other types of libraries for AAV and beyond.
Common AAV gene therapy vectors show indiscriminate transduction of living human brain cell types.
McGinnis J, Ortiz-Guzman J, Guevara M, Mallannagari S, Belfort B, Bao S bioRxiv. 2024; .
PMID: 39605617 PMC: 11601464. DOI: 10.1101/2024.11.14.623624.
Multimodal evaluation of network activity and optogenetic interventions in human hippocampal slices.
Andrews J, Geng J, Voitiuk K, Elliott M, Shin D, Robbins A Nat Neurosci. 2024; 27(12):2487-2499.
PMID: 39548326 PMC: 11881784. DOI: 10.1038/s41593-024-01782-5.
Scott S, Westhaus A, Nazareth D, Cabanes-Creus M, Navarro R, Chandra D Mol Ther Methods Clin Dev. 2024; 32(4):101351.
PMID: 39498467 PMC: 11532298. DOI: 10.1016/j.omtm.2024.101351.
The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2.
Cui M, Su Q, Yip M, McGowan J, Punzo C, Gao G Gene Ther. 2024; 31(9-10):489-498.
PMID: 39134629 PMC: 11600122. DOI: 10.1038/s41434-024-00477-7.
Zhou X, Liu J, Xiao S, Liang X, Li Y, Mo F Int J Nanomedicine. 2024; 19:7691-7708.
PMID: 39099791 PMC: 11296317. DOI: 10.2147/IJN.S459905.